CD40 and LMP-1 both signal from lipid rafts but LMP-1 assembles a distinct, more efficient signaling complex

EMBO Journal

Volumn 20, Issue 11, 2001, Pages 2641-2654

  Kaykas, A ^a   Worringer, K ^a   Sugden, B ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

CD40; Lipid rafts; LMP 1; Receptor aggregation

Indexed keywords

CD40 ANTIGEN; LIPID; MONOMER; ONCOPROTEIN; PROTEIN LMP 1; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

ANTIGENS, CD40; B-LYMPHOCYTES; BINDING SITES; CARRIER PROTEINS; CD40 LIGAND; CELL LINE; CELL LINE, TRANSFORMED; HERPESVIRUS 4, HUMAN; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE MICRODOMAINS; MODELS, MOLECULAR; PROTEIN STRUCTURE, SECONDARY; PROTEINS; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 3; TRANSFECTION; ZINC FINGERS;

EID: 0035355202     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/20.11.2641     Document Type: Article

References (58)

1. Evidence of LMP1-TRAF3 interactions in glycosphingolipid-rich complexes of lymphoblastoid and nasopharyngeal carcinoma cells
2. Degradation of the Epstein-Barr virus latent membrane protein 1 (LMP1) by the ubiquitin-proteasome pathway. Targeting via ubiquitination of the N-terminal residue
3. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40
4. The CD40 antigen and its ligand
5. Cross-linking CD40 on B cells rapidly activates nuclear factor-κB
6. Localization of the major NF-κB-activating site and the sole TRAF3 binding site of LMP-1 defines two distinct signaling motifs
7. Functions of lipid rafts in biological membranes
8. A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling
9. A role for lipid rafts in B cell antigen receptor signaling and antigen targeting
10. High concentration of the EBV latent membrane protein 1 in glycosphingolipid-rich complexes from both epithelial and lymphoid cells
11. A family of ligands for the TNF receptor superfamily
12. Membrane localization of TRAF3 enables JNK activation
13. Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain
14. Role of the TRAF binding site and NF-κB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression
15. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1)
16. Induction of the transcription factors NF-κB, AP-1 and NF-AT during B cell stimulation through the CD40 receptor
17. 2-terminal domain of gilα is sufficient to target a green fluorescent protein reporter to caveolin-enriched plasma membrane domains. Palmitoylation of caveolin-1 is required for the recognition of dually acylated g-protein α subunits in vivo
18. Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule
19. Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins
20. Characteristics of a human cell line transformed by DNA from human adenovirus type 5
21. Jak3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells
22. Caveolae, DIGs and the dynamics of sphingolipid-cholesterol microdomains
23. A fusion of the EBV latent membrane protein-1 (LMP1) transmembrane domains to the CD40 cytoplasmic domain is similar to LMP1 in constitutive activation of epidermal growth factor receptor expression, nuclear factor-κB and stress-activated protein kinase
24. Signal transduction through cytokine receptors
25. Ubiquitin-dependent internalization and down-regulation of plasma membrane proteins
26. Gettin' down with ubiquitin: Turning off cell-surface receptors, transporters and channels
27. Recruitment of CD40 and tumor necrosis factor receptor-associated factors 2 and 3 to membrane microdomains during CD40 signaling
28. Receptor-specific induction of individual AP-1 components in B lymphocytes
29. TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling
30. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-κB
31. 2 Å crystal structure of an extracellular fragment of human CD40 ligand
32. Induction of STAT protein signaling through the CD40 receptor in B lymphocytes: Distinct STAT activation following surface Ig and CD40 receptor engagement
33. The immune responses in CD40-deficient mice: Impaired immunoglobulin class switching and germinal center formation
34. Tumor necrosis factor receptor associated factor 2 is a mediator of NF-κB activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein
35. The N-terminus and membrane-spanning domains of LMP-1 inhibit cell proliferation
36. Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade
37. Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor
38. Palmitoylation of multiple Src-family kinases at a homologous N-terminal motif
39. Refined crystal structure of type III chloramphenicol acetyltransferase at 1.75 Å resolution
40. MIP-T3, a novel protein linking tumor necrosis factor receptor-associated factor 3 to the microtubule network
41. The latent membrane protein oncoprotein resembles growth factor receptors in the properties of its turnover
42. Transformation by the oncogenic latent membrane protein correlates with its rapid turnover, membrane localization and cytoskeletal association
43. Crystallographic analysis of CD40 recognition and signaling by human TRAF2
44. Stimulation of NF-κB-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus
45. Cytokine receptors: Structures and signal transduction
46. CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). Binding site specificity and activation of downstream pathways by distinct TRAFs
47. TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40
48. Characterization of LMP-1's association with TRAF1, TRAF2 and TRAF3
49. Latent membrane protein 1 of Epstein-Barr virus inhibits as well as stimulates gene expression
50. Initiation of signal transduction by receptor aggregation: Role of nonreceptor tyrosine kinases
51. Lipid rafts and signal transduction
52. Tumor necrosis factor (TNF)-mediated kinase cascades: Bifurcation of nuclear factor-κB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2
53. Polyubiquitination of the epidermal growth factor receptor occurs at the plasma membrane upon ligand-induced activation
54. Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses
55. Induced expression of trimerized intracellular domains of the human tumor necrosis factor (TNF) p55 receptor elicits TNF effects
56. Functional role of CD40 and its ligand
57. CD40-CD40 ligand
58. CD40 signaling in human dendritic cells is initiated within membrane rafts